10.07.2017 • Topics

Asahi Kasei: Lower Power Consumption Technology for the Chlor-Alkali Industry

More than 130 plants with combined production capacity of over 25 million t/y...
More than 130 plants with combined production capacity of over 25 million t/y of caustic soda are operated today based on the Asahi Kasei chlor-alkali process technology.

In 1975, Asahi Kasei began the first commercial chlor-alkali production using the membrane electrolysis process. This industrial process for the electrolysis of sodium chloride, used to manufacture caustic soda and chlorine, works without using hazardous material and with lower energy consumption than comparable processes.

Since, Asahi Kasei has strived for technical leadership in the world-wide chlor-alkali industry in the constant developments of membrane electrolysis technology, including the Aciplex-F perfluorosulfonic acid membrane, and the Acilyzer electrolyzer with operation technologies.

Recently, Asahi Kasei showcased the newly developed membrane grade Aciplex F7001X, an energy saving innovation which is to meet the customers’ strong requirements for lower power consumption in the chlor-alkali industry. The innovation will be evaluated in the market in the coming months.

More than 130 plants with combined production capacity of over 25 million t/y of caustic soda are operated today based on the Asahi Kasei chlor-alkali process technology.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read